PMID- 28987015 OWN - NLM STAT- MEDLINE DCOM- 20180822 LR - 20220318 IS - 1432-2277 (Electronic) IS - 0934-0874 (Print) IS - 0934-0874 (Linking) VI - 31 IP - 2 DP - 2018 Feb TI - Center practice drives variation in choice of US kidney transplant induction therapy: a retrospective analysis of contemporary practice. PG - 198-211 LID - 10.1111/tri.13079 [doi] AB - To assess factors that influence the choice of induction regimen in contemporary kidney transplantation, we examined center-identified, national transplant registry data for 166 776 US recipients (2005-2014). Bilevel hierarchical models were constructed, wherein use of each regimen was compared pairwise with use of interleukin-2 receptor blocking antibodies (IL2rAb). Overall, 82% of patients received induction, including thymoglobulin (TMG, 46%), IL2rAb (22%), alemtuzumab (ALEM, 13%), and other agents (1%). However, proportions of patients receiving induction varied widely across centers (0-100%). Recipients of living donor transplants and self-pay patients were less likely to receive induction treatment. Clinical factors associated with use of TMG or ALEM (vs. IL2rAb) included age, black race, sensitization, retransplant status, nonstandard deceased donor, and delayed graft function. However, these characteristics explained only 10-33% of observed variation. Based on intraclass correlation analysis, "center effect" explained most of the variation in TMG (58%), ALEM (66%), other (51%), and no induction (58%) use. Median odds ratios generated from case-factor adjusted models (7.66-11.19) also supported large differences in the likelihood of induction choices between centers. The wide variation in induction therapy choice across US transplant centers is not dominantly explained by differences in patient or donor characteristics; rather, it reflects center choice and practice. CI - (c) 2017 Steunstichting ESOT. FAU - Dharnidharka, Vikas R AU - Dharnidharka VR AUID- ORCID: 0000-0001-8000-1385 AD - Department of Pediatrics, Division of Nephrology, Washington University School of Medicine, St. Louis, MO, USA. FAU - Naik, Abhijit S AU - Naik AS AD - Department of Medicine, Division of Nephrology, University of Michigan, Ann Arbor, MI, USA. FAU - Axelrod, David A AU - Axelrod DA AD - Department of Surgery, Division of Transplantation, Lahey Clinic, Burlington, MA, USA. FAU - Schnitzler, Mark A AU - Schnitzler MA AD - Center for Abdominal Transplantation, Saint Louis University School of Medicine, St. Louis, MO, USA. FAU - Zhang, Zidong AU - Zhang Z AD - Center for Abdominal Transplantation, Saint Louis University School of Medicine, St. Louis, MO, USA. FAU - Bae, Sunjae AU - Bae S AD - Center for Transplantation, Johns Hopkins School of Medicine, Baltimore, MD, USA. FAU - Segev, Dorry L AU - Segev DL AD - Center for Transplantation, Johns Hopkins School of Medicine, Baltimore, MD, USA. FAU - Brennan, Daniel C AU - Brennan DC AD - Center for Transplantation, Johns Hopkins School of Medicine, Baltimore, MD, USA. FAU - Alhamad, Tarek AU - Alhamad T AD - Transplant Nephrology, Washington University School of Medicine, St. Louis, MO, USA. FAU - Ouseph, Rosemary AU - Ouseph R AD - Center for Abdominal Transplantation, Saint Louis University School of Medicine, St. Louis, MO, USA. FAU - Lam, Ngan N AU - Lam NN AD - Division of Nephrology, University of Alberta, Edmonton, AB, Canada. FAU - Nazzal, Mustafa AU - Nazzal M AD - Center for Abdominal Transplantation, Saint Louis University School of Medicine, St. Louis, MO, USA. FAU - Randall, Henry AU - Randall H AD - Center for Abdominal Transplantation, Saint Louis University School of Medicine, St. Louis, MO, USA. FAU - Kasiske, Bertram L AU - Kasiske BL AD - Department of Medicine, Hennepin County Medical Center, Minneapolis, MN, USA. FAU - McAdams-Demarco, Mara AU - McAdams-Demarco M AD - Center for Transplantation, Johns Hopkins School of Medicine, Baltimore, MD, USA. FAU - Lentine, Krista L AU - Lentine KL AUID- ORCID: 0000-0002-9423-4849 AD - Center for Abdominal Transplantation, Saint Louis University School of Medicine, St. Louis, MO, USA. LA - eng GR - R01 DK102981/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Multicenter Study PT - Research Support, N.I.H., Extramural DEP - 20171102 PL - Switzerland TA - Transpl Int JT - Transplant international : official journal of the European Society for Organ Transplantation JID - 8908516 RN - 0 (Antibodies, Monoclonal, Humanized) SB - IM MH - Adult MH - Antibodies, Monoclonal, Humanized/pharmacology/*therapeutic use MH - Cohort Studies MH - Female MH - Graft Rejection/immunology/*prevention & control MH - Graft Survival MH - Humans MH - Kidney Failure, Chronic/diagnosis/mortality/surgery MH - Kidney Transplantation/adverse effects/*methods MH - Male MH - Middle Aged MH - Precision Medicine/*methods MH - Registries MH - Remission Induction/*methods MH - Retrospective Studies MH - Risk Assessment MH - Survival Analysis MH - Tissue and Organ Procurement/organization & administration MH - Transplantation Immunology MH - Treatment Outcome MH - United States MH - Young Adult PMC - PMC5862637 MID - NIHMS911685 OTO - NOTNLM OT - immunosuppression OT - induction OT - kidney transplantation OT - practice patterns COIS- DISCLOSURES/CONFLICTS OF INTEREST: The authors report no conflicts of interest. EDAT- 2017/10/08 06:00 MHDA- 2018/08/23 06:00 PMCR- 2019/02/01 CRDT- 2017/10/08 06:00 PHST- 2017/07/10 00:00 [received] PHST- 2017/08/29 00:00 [revised] PHST- 2017/09/28 00:00 [accepted] PHST- 2017/10/08 06:00 [pubmed] PHST- 2018/08/23 06:00 [medline] PHST- 2017/10/08 06:00 [entrez] PHST- 2019/02/01 00:00 [pmc-release] AID - 10.1111/tri.13079 [doi] PST - ppublish SO - Transpl Int. 2018 Feb;31(2):198-211. doi: 10.1111/tri.13079. Epub 2017 Nov 2.